DCVMN at the Vaccine Innovation Forum 2025 strengthening global vaccine access! DCVMN International is committed to ensuring that vaccine manufacturers in developing countries have a strong voice in shaping the future of global health. As part of this mission, our CEO, Rajinder Suri, participated in the Vaccine Innovation Forum 2025 in Shanghai, China, engaging in critical discussions on vaccine equity, innovation, and accessibility.
๐น ๐ฃ๐น๐ฒ๐ป๐ฎ๐ฟ๐ ๐ฃ๐ฎ๐ป๐ฒ๐น: ๐๐น๐ผ๐ฏ๐ฎ๐น ๐ฉ๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐๐พ๐๐ถ๐๐
In the Plenary Panel chaired by Dr. Raman Rao, Rajinder Suri joined global leaders to address the challenges in vaccine distribution and access, emphasizing the need for sustainable solutions that empower vaccine manufacturers in developing countries in order to strengthen global health security.
๐น ๐๐๐ฉ๐ ๐ก ๐๐ผ๐ฟ๐๐บ
Co-chaired by Rajinder Suri and Andrew Wong from member company Walvax Biotechnology, the forum brought together experts from PATH, Gates Foundation, Biokangtai, SK bioscience, and SPbSRIVS FMBA of Russia to discuss key issues, including:
– Strengthening vaccine manufacturing in developing countries
– Innovations tailored for low-resource settings
– Chinaโs vaccine development landscape
– Tech transfer strategies for sustainable production
– Lessons from Latin Americaโs vaccine initiatives
– The future of global HPV vaccine introduction
The discussions reinforced the ๐ฐ๐ฟ๐ถ๐๐ถ๐ฐ๐ฎ๐น ๐ป๐ฒ๐ฒ๐ฑ ๐ณ๐ผ๐ฟ ๐ฐ๐ผ๐น๐น๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ถ๐ผ๐ป, ๐๐ฒ๐ฐ๐ต๐ป๐ผ๐น๐ผ๐ด๐ ๐๐ฟ๐ฎ๐ป๐๐ณ๐ฒ๐ฟ, ๐ฎ๐ป๐ฑ ๐๐๐๐๐ฎ๐ถ๐ป๐ฎ๐ฏ๐น๐ฒ ๐๐ฎ๐ฐ๐ฐ๐ถ๐ป๐ฒ ๐บ๐ฎ๐ป๐๐ณ๐ฎ๐ฐ๐๐๐ฟ๐ถ๐ป๐ด to ensure equitable access worldwide. A sincere thank you to all our member companies, partners, and global health leaders who contributed to these critical conversations.
Together, we continue to advance equitable and sustainable vaccine access for all!
